Coevolution of NK and Tumor Cell States Along Multiple Myeloma Progression from Precursor Conditions
International Journal of Molecular Sciences · 22.05.2026 · 27 (11) · 4682
DOI: 10.3390/ijms27114682 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.05.2026. Verfasst von Cristina Aquilina und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Ita…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Multiple Myeloma. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Next Generation EU, My First Airc Grant (MFAG), PRIN 2022.
Abstract (Originalsprache)
Multiple myeloma (MM) develops through asymptomatic precursor stages characterized by progressive remodeling of the bone marrow (BM) immune microenvironment and disruption of bone homeostasis. To delineate changes in natural killer (NK) cell states during disease evolution, we investigated coordinated immune-tumor remodeling by integrating NK cell functional states with plasma cell-intrinsic susceptibility programs derived from CRISPR-based screens across healthy donors (HD), monoclonal gammopathy of undetermined significance (MGUS), smoldering MM (SMM), and newly diagnosed MM patients. The integration of NK cell state-associated gene signatures with plasma cell transcriptional programs revealed stage-specific co-variation between immune and tumor compartments. Public single-cell RNA sequencing datasets were interrogated to resolve NK cell heterogeneity, identifying cytotoxic CD56dim and regulatory CD56bright subsets. NK cell dynamics displayed stage-dependent changes, with early expansion followed by the contraction of CD56dim cells in BM, whereas CD56bright cells showed predominantly compositional remodeling. Within the CD56bright subset, transcriptional changes included an increased expression of KLRC1 (encoding NKG2A), subsequently validated by multiparametric flow cytometry. In parallel, plasma cell programs associated with NK sensitivity progressively decreased along disease stages, supporting tumor adaptation to immune pressure. The NKG2A ligand HLA-E displayed selective expression within CD16+ monocytes and followed a distinct variable pattern across disease stages, highlighting a microenvironmental contribution to NK cell regulation. Collectively, these findings indicate a coordinated process of immune-tumor co-evolution, characterized by dynamic remodeling of NK cell states and plasma cell susceptibility, with the NKG2A–HLA-E axis emerging as a central interface during MM progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
- Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), University of Palermo, 90127 Palermo, Italy.
- Department of Surgical, Oncological and Stomatological Disciplines (DICHIRONS), University of Palermo, 90127 Palermo, Italy.
- Hematology Section, Department of General Surgery and Medical-Surgical Specialties, University of Catania, 95123 Catania, Italy.
- General Orthopedics, IRCCS Rizzoli Orthopedic Institute, 40136 Bologna, Italy.
- Department of Orthopaedics and Traumatology, University of Palermo, 90127 Palermo, Italy.
ORCID-Profile: Cristina Aquilina, Andrea Romano, Anna Maria Corsale, Maria Speciale, Marta Di Simone, Angelo Toscano, Gianluca Giavaresi, Lavinia Raimondi, Nadia Caccamo, Francesco Dieli, Serena Meraviglia, Cirino Botta
Förderung
- European Union, Next Generation EU
- My First Airc Grant (MFAG)
- PRIN 2022
- PRIN PNRR 2022
- PRINN PNRR 2022
- European Commission Mission Cancer (ELMUMY)
- Sicilian MicronanoTech Research And Innovation Center (SAMOTHRACE)
Zitieren
APA
Aquilina, C., Romano, A., Corsale, A. M., Biondo, M., Speciale, M., Tofacchi, E., Di Simone, M., Gigliotta, E., Dieli, C., Avellone, C., Toscano, A., Camarda, L., Romano, A., Cambria, D., Giavaresi, G., Raimondi, L., Neri, A., Campana, S., Caccamo, N., …, & Botta, C. (2026). Coevolution of NK and Tumor Cell States Along Multiple Myeloma Progression from Precursor Conditions. International Journal of Molecular Sciences, 27(11), 4682. https://doi.org/10.3390/ijms27114682
Vancouver
Aquilina C, Romano A, Corsale AM, Biondo M, Speciale M, Tofacchi E, et al. Coevolution of NK and Tumor Cell States Along Multiple Myeloma Progression from Precursor Conditions. International Journal of Molecular Sciences. 2026;27(11):4682. doi:10.3390/ijms27114682
BibTeX
@article{Aquilina2026,
author = {Aquilina, Cristina and Romano, Andrea and Corsale, Anna Maria and Biondo, Marta and Speciale, Maria and Tofacchi, Elena and Di Simone, Marta and Gigliotta, Emilia and Dieli, Costanza and Avellone, Claudia and Toscano, Angelo and Camarda, Lawrence and Romano, Alessandra and Cambria, Daniela and Giavaresi, Gianluca and Raimondi, Lavinia and Neri, Antonino and Campana, Stefania and Caccamo, Nadia and Dieli, Francesco and Siragusa, Sergio and Meraviglia, Serena and Botta, Cirino},
title = {Coevolution of NK and Tumor Cell States Along Multiple Myeloma Progression from Precursor Conditions},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4682},
doi = {10.3390/ijms27114682}
}
EUVIMED